ALX Oncology (ALXO) news
Recent news
Payward-Saldo deal seen closing in 2027
The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
AInvest Wire · 1d agoGalp - Q3 sales of oil products to clients 2.0 mln tonnes
AInvest Wire · 2d agoTavexia Lifecare - Board approves acquisition of 60% controlling stake in Meyonex Pharmaceuticals
Tavexia Lifecare Limited (TAVX) has announced that its board of directors has approved the acquisition of a 60% controlling stake in Meyonex Pharmaceuticals. The move is expected to strengthen Tavexia’s position in the pharmaceutical sector by expanding its product portfolio and enhancing its…
AInvest Wire · 2d agoAlx Oncology reports inducement grant as permitted by the Nasdaq listing rules
AInvest Wire · Jun 30, 2026Alx Oncology Holdings - secures term loan facility up to $50 mln, $10 mln uncommitted - SEC filing
ALX Oncology Holdings Inc. (Nasdaq: ALXO) has secured a term loan facility of up to $50 million, with an initial draw of $10 million, as disclosed in a recent SEC filing . The loan, provided by Oxford Finance LLC and Silicon Valley Bank, is part of a broader $100 million financing agreement…
AInvest Wire · Jun 26, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.